The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Modulation of the Activity of Pyramidal Neurons in Rat Prefrontal Cortex by Raphe Stimulation In Vivo: Involvement of Serotonin and GABA
Abstract
Serotonin is involved in psychiatric disorders exhibiting abnormal prefrontal cortex (PFC) function (e.g. major depression, schizophrenia). We examined the effect of the stimulation of the dorsal and median raphe nuclei (DR and MnR, respectively) on the activity of PFC neurons. Electrical stimulation of DR/MnR inhibited 66% (115/173) of pyramidal neurons in the medial PFC (mPFC). The rest of the cases exhibited orthodromic excitations, either pure (13%) or preceded by short-latency inhibitions (20%). Excited neurons had a lower pre-stimulus firing rate than those inhibited. Excitations evoked by MnR stimulation had a shorter latency than those evoked by DR stimulation. WAY-100635 [a 5-hydroxytryptamine1A (5-HT1A) antagonist] and the selective gamma aminobutyric acidA (GABAA) antagonist picrotoxinin partially antagonized DR/MnR-evoked inhibitions, suggesting the involvement of 5-HT1A- and GABAA-mediated components. The presence of a direct DR/MnR-mPFC GABAergic component is suggested by the short latency of evoked inhibitions (9 +/- 1 ms), faster than those evoked in the secondary motor area (20 +/- 3 ms), and that of antidromic spikes evoked by DR/MnR stimulation in mPFC pyramidal neurons (15 +/- 1 ms). Stimulation of the DR/MnR with paired pulses enhanced the duration of inhibitions and turned some excitations into inhibitions. Thus, the DR/MnR control the activity of mPFC pyramidal neurons in vivo in a complex manner, involving 5-HT-mediated excitations and GABA- and 5-HT-mediated inhibitions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593 · cited 2×
“…is critically involved in working memory and cognition through a complex control of the activity of pyramidal neurons (Glowinski et al., 1984; Williams and Goldman-Rakic, 1995; Goldman-Rakic, 1996; Yang and Seamans, 1996; Robbins, 2000; Tzschentke, 2001; O’Donnell, 2003; Wang et al., 2003).”
BackgroundDifferential projections of the infralimbic and prelimbic cortex in the rat
Vertes, R. P. (2004) · Synapse · doi:10.1002/syn.10279 · Cited by 1,550
A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons
Gras, C., Herzog, E., Bellenchi, G. C., Bernard, V., Ravassard, P., Pohl, M., Gasnier, B., Giros, B., & El Mestikawy, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05442.2002 · Cited by 639
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497
Self-citationSantana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Tzschentke, T. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00033-2 · Cited by 481 · cited 1×
“…is critically involved in working memory and cognition through a complex control of the activity of pyramidal neurons (Glowinski et al., 1984; Williams and Goldman-Rakic, 1995; Goldman-Rakic, 1996; Yang and Seamans, 1996; Robbins, 2000; Tzschentke, 2001; O’Donnell, 2003; Wang et al., 2003).”
BackgroundAmargos-Bosch, M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg128 · Cited by 370
The Physiological Role of 5-HT2AReceptors in Working Memory
Williams, G. V., Rao, S. G., & Goldman-Rakic, P. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02843.2002 · Cited by 311 · cited 2×
“5-HT2A receptors in dorsolateral PFC are involved in working memory (Williams et al., 2002), and recent work associates allelic variants of this receptor with memory capacity in humans (De Quervain et al.”
BackgroundMiner, L. A. H., Backstrom, J. R., Sanders-Bush, E., & Sesack, S. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00580-8 · Cited by 216
Férézou, I., Cauli, B., Hill, E. L., Rossier, J., Hamel, E., & Lambolez, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07389.2002 · Cited by 215 · cited 5×
“First, 5-HT has been shown to activate excitatory 5-HT2A and 5-HT3 receptors in mPFC GABAergic interneurons, thus increasing a GABAergic input onto pyramidal neurons (Ashby et al., 1989, 1990; Tanaka and North, 1993; Zhou and Hablitz, 1999; Férézou et al., 2002; Puig et al., 2004).”
BackgroundInfluential
Cited by
Amat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., & Maier, S. F. (2005) · Nature Neuroscience · doi:10.1038/nn1399 · Cited by 931
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462
“Additionally, cortico-mesencephalic pyramidal neurons respond to 5-HT1A and/or 5-HT2A receptor activation, as indicated by in vivo physiological (Puig et al., 2005) and pharmacological studies (Celada et al.”
BackgroundInfluentialSelf-citationLesch, K.-P., & Waider, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.013 · Cited by 435
Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits
Puig, M. V., & Gulledge, A. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8214-0 · Cited by 421
“Indeed, GABA projection neurons have been found in the dorsal raphe nucleus [124], and some inhibitory responses recorded in PFC neurons have a fast component blocked by the GABAA receptor antagonist picrotoxin [20].”
BackgroundMethodInfluentialSelf-citationWellman, C. L., Izquierdo, A., Garrett, J. E., Martin, K. P., Carroll, J., Millstein, R., Lesch, K.-P., Murphy, D. L., & Holmes, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4595-06.2007 · Cited by 366
Psychedelics as Medicines: An Emerging New Paradigm
Nichols, D., Johnson, M., & Nichols, C. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.557 · Cited by 370
The Serotonin-1A Receptor in Anxiety Disorders
Akimova, E., Lanzenberger, R., & Kasper, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.012 · Cited by 360
Celada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs · doi:10.1007/s40263-013-0071-0 · Cited by 323
“pyramidal neurons due to the direct stimulation of 5-HT1ARs located on the recorded cells [50], in agreement with the inhibitory actions of 5-HT1A-R activation [51].”
Reduced Serotonin-1A Receptor Binding in Social Anxiety Disorder
Lanzenberger, R. R., Mitterhauser, M., Spindelegger, C., Wadsak, W., Klein, N., Mien, L.-K., Holik, A., Attarbaschi, T., Mossaheb, N., Sacher, J., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.022 · Cited by 300
Díaz-Mataix, L., Scorza, M. C., Bortolozzi, A., Toth, M., Celada, P., & Artigas, F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2999-05.2005 · Cited by 285
Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease
Holmes, A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.006 · Cited by 264
Calizo, L. H., Akanwa, A., Ma, X., Pan, Y.-Z., Lemos, J. C., Craige, C., Heemstra, L. A., & Beck, S. G. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.008 · Cited by 252
Evers, E. A. T., Cools, R., Clark, L., van der Veen, F. M., Jolles, J., Sahakian, B. J., & Robbins, T. W. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300663 · Cited by 208
Llado-Pelfort, L., Santana, N., Ghisi, V., Artigas, F., & Celada, P. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr220 · Cited by 156
Self-citationNarayanan, V., Heiming, R. S., Jansen, F., Lesting, J., Sachser, N., Pape, H.-C., & Seidenbecher, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022600 · Cited by 103
“The loss of 5-HT clearance in 5-HTT KO mice [77] produces marked increases in extracellular levels and reduced turnover [29] of 5-HT in several brain regions, including frontal cortex [28], and electrophysiological data indicate that activation of serotonergic input to the mPFC inhibits the majority of pyramidal neuro…”
BackgroundTwo dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
Lewis, C. R., Preller, K. H., Kraehenmann, R., Michels, L., Staempfli, P., & Vollenweider, F. X. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.07.020 · Cited by 102
Gronier, B., Savignac, H. M., Di Miceli, M., Idriss, S. M., Tzortzis, G., Anthony, D., & Burnet, P. W. J. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.001 · Cited by 91
Bekinschtein, P., Renner, M. C., Gonzalez, M. C., & Weisstaub, N. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2087-13.2013 · Cited by 69
Robinson, O. J., Overstreet, C., Allen, P. S., Letkiewicz, A., Vytal, K., Pine, D. S., & Grillon, C. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.03.075 · Cited by 64
De Kock, C. P. J., Cornelisse, L. N., Burnashev, N., Lodder, J. C., Timmerman, A. J., Couey, J. J., Mansvelder, H. D., & Brussaard, A. B. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.115311 · Cited by 55
Gronier, B. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.11.002 · Cited by 44
A Digitally Assisted, Signal Folding Neural Recording Amplifier
Chen, Y., Basu, A., Liu, L., Zou, X., Rajkumar, R., Dawe, G. S., & Je, M. (2014) · IEEE Transactions on Biomedical Circuits and Systems · doi:10.1109/tbcas.2013.2288680 · Cited by 43
“At 3–4 mm beneath the skull, pyramidal neurons of the prefrontal cortex were encountered and identified according to their electrophysiological characteristics as described previously [29]–[31].”
MethodThe Role of Serotonin in Orbitofrontal Function and Obsessive-Compulsive Disorder
Maia, T. V., & Cano-Colino, M. (2015) · Clinical Psychological Science · doi:10.1177/2167702614566809 · Cited by 42
Jung, H. Y., Kim, D. W., Nam, S. M., Kim, J. W., Chung, J. Y., Won, M.-H., Seong, J. K., Yoon, Y. S., Yoo, D. Y., & Hwang, I. K. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.09.006 · Cited by 23
Metadata
- Authors
- Puig, M. V.
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07-06
- Volume
- 15
- Issue
- 1
- Pages
- 1-14
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2141403390
- Cited by
- 231
- References
- 10
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.